

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100mg | 360 pills | NZ$1.78 | NZ$803.17 NZ$642.54 Best Price | |
| 100mg | 270 pills | NZ$1.83 | NZ$618.73 NZ$494.99 | |
| 100mg | 180 pills | NZ$1.93 | NZ$434.29 NZ$347.43 | |
| 100mg | 120 pills | NZ$2.09 | NZ$315.30 NZ$252.24 | |
| 100mg | 90 pills | NZ$2.28 | NZ$255.80 NZ$204.64 | |
| 100mg | 60 pills | NZ$2.57 | NZ$193.33 NZ$154.67 | |
| 100mg | 30 pills | NZ$3.57 | NZ$133.84 NZ$107.07 | |
| 200mg | 360 pills | NZ$1.90 | NZ$856.72 NZ$685.37 Popular | |
| 200mg | 270 pills | NZ$1.98 | NZ$666.33 NZ$533.06 | |
| 200mg | 180 pills | NZ$2.09 | NZ$469.99 NZ$375.99 | |
| 200mg | 120 pills | NZ$2.26 | NZ$339.10 NZ$271.28 | |
| 200mg | 90 pills | NZ$2.43 | NZ$273.65 NZ$218.92 | |
| 200mg | 60 pills | NZ$2.78 | NZ$208.21 NZ$166.57 | |
| 200mg | 30 pills | NZ$3.81 | NZ$142.76 NZ$114.21 |
Disclaimer: This information is for residents of New Zealand and is not a substitute for medical advice. Consultation with a healthcare professional is recommended before starting, stopping, or altering Provigil (modafinil) therapy.
Narcolepsy is a chronic sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks, which can disrupt work, school, and daily activities. Studies suggest that wakefulness-promoting medicines can help manage daytime sleepiness in affected individuals.
Provigil contains the active ingredient modafinil, a wakefulness-promoting drug in the eugeroic class. The exact mechanism is not fully understood, but it is believed to influence brain systems that regulate alertness.
Provigil is used to reduce daytime sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSA-HS), and shift work sleep disorder (SWSD). It is intended to improve wakefulness during the day and support functioning in daily activities when sleepiness is a prominent symptom.
This medication is typically prescribed under medical supervision and is not a cure for the underlying sleep disorder. The goal is to improve alertness during waking hours while addressing sleep quality and nighttime breathing where relevant.
Provigil should be taken exactly as directed by a clinician. The information provided here is for general understanding and does not replace the official product leaflet or medical advice. If any aspect of this information is unclear, consult a pharmacist or doctor for personalised guidance.
Excessive daytime sleepiness is the principal symptom in narcolepsy and is often described as an overwhelming urge to sleep during the day, despite adequate nighttime sleep. This can affect performance at work or school and can lead to fatigue and mood changes.
In obstructive sleep apnea/hypopnea syndrome, daytime sleepiness may persist even when breathing disturbances during sleep are managed with standard therapies. Provigil may help maintain wakefulness during the day in these circumstances.
Shift work sleep disorder occurs when work schedules conflict with the body’s natural sleep-wake cycle. Provigil may improve alertness during waking hours for some people with SWSD, supporting safer performance at work and daily activities.
Provigil is not a treatment for the underlying causes of these conditions. Non-pharmacological approaches and condition-specific therapies remain important components of care. If there is any doubt about suitability, a clinician should be consulted to review individual circumstances and alternatives.
Ongoing assessment by a healthcare professional is encouraged to determine whether Provigil is appropriate as part of a comprehensive management plan for daytime sleepiness. If symptoms persist or worsen, medical advice should be sought promptly.
The precise mechanism by which modafinil promotes wakefulness is not completely understood. It is thought to enhance activity in brain networks that regulate alertness without producing the same level of stimulation as some older stimulant medicines.
Modafinil appears to affect several neurochemical systems, including histamine release in the brain and, to a lesser extent, dopamine signaling in certain areas. This combination is believed to contribute to improved wakefulness during the day.
In addition, modulators of the orexin (hypocretin) system may play a role in sustaining arousal, which can help reduce daytime sleepiness in susceptible individuals. The overall effect is an increased ability to stay awake and function during waking hours.
Because responses vary between individuals, the exact pattern of action may differ. A clinician can explain how Provigil is expected to work in relation to a specific sleep disorder and daily routine. If any concerns arise about effectiveness or tolerability, medical advice should be sought.
Provigil is not a general stimulant designed to override fatigue in all circumstances; it is a targeted wakefulness-promoting therapy administered under medical supervision. Ongoing monitoring helps ensure the most appropriate use for each patient.
Provigil should be taken exactly as prescribed by a healthcare professional. Rates of response and required doses vary among individuals and conditions, and dosing may be adjusted over time to achieve the best balance of benefit and tolerability.
Tablets are usually taken by mouth with water. They should be swallowed whole; do not crush or chew the tablet unless advised by a clinician. The recommended timing depends on the condition being treated and daily routine.
For narcolepsy or OSA-HS, morning dosing is common to promote daytime wakefulness. For SWSD, dosing is often scheduled prior to the work shift to help maintain alertness during work hours. If a dose is missed, guidance should be sought from a clinician rather than duplicating doses without direction.
Food may have a variable effect on absorption in some individuals; it is generally acceptable to take Provigil with or without food unless instructed otherwise by a clinician. Consistency in administration timing can help maintain steady effects and symptom control.
In all cases, use should be aligned with the official product information and the prescribing clinician’s plan. If there is uncertainty about timing, missed doses, or adjustments, contact a pharmacist or doctor for personalised instructions before making changes.
A known allergy or hypersensitivity to modafinil, armodafinil, or any component of the product is a contraindication to use. In such cases, Provigil should not be taken because allergic reactions can be serious.
Provigil is not approved for use in children under 18 years of age. Safety and effectiveness in younger patients have not been established through appropriate evidence in standard practice.
Individuals with significant liver impairment or active certain medical conditions should discuss risk and benefit with a clinician. Pre-existing severe psychiatric disorders, particularly those with a risk of psychosis or suicidality, require careful evaluation before initiation.
Concomitant use with some medications and certain medical situations may require exclusion or close monitoring. Pregnancy and breastfeeding require careful consideration, and alternative options should be discussed with a clinician. The presence of any of these conditions warrants a professional evaluation prior to starting Provigil.
In all cases, the decision to commence Provigil should be made in consultation with a healthcare professional, who can assess risks based on medical history and current therapies.
Common adverse effects may include headache, nausea, dizziness, dry mouth, insomnia, or nervousness. These effects are usually mild to moderate and may diminish with continued use or dose adjustments.
Serious adverse reactions have been reported rarely. Seek urgent medical help if signs of a severe skin reaction occur, such as widespread rash, swelling, or peeling skin, or if there is swelling of the face or lips, difficulty breathing, or other signs of an allergic reaction.
Neuropsychiatric changes, including mood swings, anxiety, agitation, or new or worsening psychiatric symptoms, should be discussed with a clinician. Behavioral changes warrant prompt medical review to determine whether treatment should continue.
Provigil can affect the ability to drive or operate machinery, especially when starting treatment or adjusting the dose. If daytime sleepiness or dizziness occurs, activity should be limited until alertness improves. Guidance should be sought from a clinician if driving safety is a concern.
All medicines, supplements, and herbal products should be disclosed to the prescribing clinician to assess potential interactions. Regular follow-up appointments assist in monitoring efficacy and safety over time.
Most people tolerate Provigil well, with common side effects including headache, nausea, dry mouth, and trouble sleeping. These effects are usually manageable and temporary.
Other possible effects include dizziness, anxiety, irritability, decreased appetite, or stomach upset. If these become troublesome, contact a clinician for advice on management or dose adjustments.
Allergic reactions are uncommon but may occur. Severe skin reactions, swelling of the face or tongue, or difficulty breathing require immediate medical attention and discontinuation of the medicine.
If any side effect persists, worsens, or causes concern, a pharmacist or doctor should be consulted. Do not stop Provigil suddenly without professional guidance unless advised by a clinician in an urgent situation.
Routinely monitor for any unusual changes in mood, sleep patterns, or energy levels, and report these during follow-up visits or calls with a healthcare professional.
Modafinil may interact with certain medicines. Inform the prescribing clinician about all current prescriptions, over‑the‑counter medicines, and herbal products to assess potential interactions.
Concomitant use with monoamine oxidase inhibitors (MAOIs) is generally avoided or requires special consideration due to potential risks. A clinician will determine any necessary precautions or alternatives.
Some hormonal contraceptives may have reduced effectiveness when taken with modafinil. Additional or alternative contraception should be discussed with a clinician as part of risk management.
Alcohol consumption should be discussed with a clinician, as it can influence sleep quality and the overall tolerability of Provigil. Caffeine and other stimulants may interact indirectly by affecting wakefulness and anxiety levels, and should be used with caution.
It is important to review all medicines with a healthcare professional to identify potential interactions and to adjust therapy as needed. If any new medication is started, a clinician should be informed promptly about Provigil use.
Pregnancy should be planned carefully, and the use of Provigil during pregnancy requires careful consideration of potential risks and benefits. If pregnancy is possible or confirmed, a clinician should be consulted promptly.
There is limited information on safety in pregnancy, and the decision to continue Provigil during pregnancy is individualized based on clinical needs. Alternatives may be discussed if pregnancy occurs or is planned.
Breastfeeding is generally not recommended during Provigil use, as the medication may pass into breast milk. A clinician can discuss the safest options for infant feeding while managing daytime sleepiness in the mother.
For individuals who are pregnant, planning pregnancy, or breastfeeding, medical advice is essential to weigh benefits and risks and to determine the most appropriate course of action.
If pregnancy occurs while taking Provigil, contact a healthcare professional for guidance on next steps and potential adjustments to therapy.
Provigil is approved for specific sleep disorders and their associated daytime sleepiness. For other conditions, use should be guided by a clinician, who can assess whether benefits may be present and safe.
Some individuals notice improved alertness within a few days, while others may require several weeks. A clinician can help gauge response and determine whether continued treatment is appropriate.
If a dose is missed, take it as soon as remembered unless the next scheduled dose is soon. Do not double the dose to catch up. If uncertainty remains, contact a clinician for instruction.
Alcohol should be used with caution. It can worsen sleep problems and interact with daytime wakefulness strategies. Discuss personal use with a clinician to determine safe practices.
Long-term use may be appropriate for certain conditions under ongoing medical supervision. Regular review is advised to assess continued need, effectiveness, and tolerability.
Some hormonal contraceptives may be less effective when used with modafinil. Additional contraception or alternative methods should be discussed with a clinician if this is a concern.
Most patients do not experience withdrawal in the conventional sense, but daytime sleepiness may recur if treatment is discontinued without a plan. Guidance from a clinician should be sought before stopping therapy.
Driving or operating machinery should be evaluated on an individual basis. If sleepiness or dizziness persists, driving should be avoided until wakefulness improves and guidance is provided by a clinician.
Evidence in older adults is more limited. Clinicians consider age-related factors, comorbidities, and interacting medications when determining suitability and dosing.
Discontinue Provigil immediately and seek urgent medical help. A clinician should be informed promptly to assess the reaction and determine the next steps.
Provigil is a wakefulness-promoting agent with a distinct pharmacological profile compared to classic stimulants. Individual responses vary, and expectations should be discussed with a clinician.
The official patient information leaflet accompanying Provigil contains detailed information on ingredients, dosing guidelines, warnings, and safety data. It should be reviewed carefully before starting treatment and during follow-up visits.
Consultation with a pharmacist or clinician is encouraged for personalised advice, medication reviews, and management of any side effects or interactions. They can also help clarify how Provigil fits within a broader sleep-disorder management plan.
For authoritative information, refer to the product label and the NZ regulatory authority’s consumer information materials. If symptoms persist, worsen, or new concerns arise, contact a healthcare professional promptly for assessment and adjustments to therapy.
Keep all medical information up to date, including current medications, allergies, and medical conditions, to support safe and effective use of Provigil. In case of urgency or a medical emergency, seek appropriate professional help without delay.
When seeking additional information, rely on verified sources and the advice of a clinician to ensure decisions are appropriate for the individual’s health status and local guidelines.
14–21 days. Free from NZ$342.92 .
5–9 days. NZ$51.44
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.